James Mulay, Director at CG Oncology, Inc. (CGON), sold 11,806 shares at $43.99 ($519K) on 2025-10-09, disclosed to the SEC on 2025-10-10.
Scheduled sale ($519k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.99 | 5,903 | $260K | 50.0% |
| 2 | $43.99 | 5,903 | $260K | 50.0% |
| Total | $43.99 avg | 11,806 | $519K | 100% |
| Filing → |
| CGON | SELL | 2026-04-20 | $1.1M | — | Filing → |
| CGON | SELL | 2026-03-17 | $125K | — | Filing → |
| CGON | SELL | 2026-01-13 | $585K | — | Filing → |